|
|
|
Volumn 16, Issue 8 Suppl, 2010, Pages
|
|
The current landscape and unmet needs in multiple sclerosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA INTERFERON;
BETA1A INTERFERON;
GLATIRAMER;
IMMUNOLOGICAL ADJUVANT;
INTERFERON BETA SERINE;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
NEUROPROTECTIVE AGENT;
PEPTIDE;
CLINICAL TRIAL (TOPIC);
DISEASE COURSE;
DRUG ADMINISTRATION ROUTE;
HUMAN;
MULTIPLE SCLEROSIS;
REMISSION;
REVIEW;
ADJUVANTS, IMMUNOLOGIC;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS AS TOPIC;
DISEASE PROGRESSION;
DRUG ADMINISTRATION ROUTES;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
NEUROPROTECTIVE AGENTS;
PEPTIDES;
REMISSION INDUCTION;
|
|
EID: 79952116408
PISSN: None
EISSN: 19362692
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (14)
|
|
References (0)
|
